Podcasts about Translational Research Institute

During our first episode of Season 2 of Research Ethics Reimagined, Guest Host Robert Nobles, DrPH, MPH, CIP takes us beyond our usual conversations into the cosmos—literally. Our guest is Rachael Dempsey, the Chief Operations and Communications Officer at the Translational Research Institute for Space Health, also known as TRISH. TRISH is at the forefront of safeguarding human health in space, working alongside NASA and leading institutions like Baylor College of Medicine, MIT, and Caltech to tackle the challenges of long-duration space travel.  

The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:1. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial. Alzheimer's Research & Therapy https://doi.org/10.1186/s13195-024-01482-z (2024) 16:122Guest:Philip Lieberman, MDResident – Family Medicine Residency ProgramJefferson Health – Abington2. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 DiabetesGuest: Richard E. Pratley , MDMedical Director at the AdventHealth Diabetes InstituteSenior Investigator, Diabetes Program Lead at the Translational Research Institute 3. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver FibrosisGuest: Richard Potter, MDResident – Family Medicine Residency ProgramJefferson Health – AbingtonMedical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA. This Podcast Episode does not offer CME/CE Credit. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

“The HemOnc Pulse” goes on the road to Chicago May 3-4 with host Chadi Nabhan, MD, MBA, FACP, for the first live meeting. This podcast episode features a panel discussion on unanswered questions in chimeric antigen receptor (CAR) T-cell therapy with Caron Jacobson, MD, MMSc, Medical Director of the Immune Effector Cell Therapy Program at Dana-Farber Cancer Institute; Michael Bishop, MD, FACP, FASCO, Director of the Hematopoietic Stem Cell Transplantation Program at the University of Chicago; Joseph Mikhael, MD, MEd, FRCPC, FACP, a Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Research Institute, an affiliate of the City of Hope Cancer Center; and Alan Skarbnik, MD, Director of the Lymphoma and Chronic Lymphocytic Leukemia Program and Director of Experimental Therapeutics, Malignant Hematology at Novant Health.

In this episode I'm digging deeper into the purported health effects of deuterium, a stable isotope of hydrogen. Deuterium has twice the mass of hydrogen, and it exists naturally in water.  A hydrogen atom in H2O is replaced by deuterium in about 150 out of 1 million atoms. This trace compound interacts chemically as hydrogen, but because of its weight it has different dynamics. Why is this an issue? Excess deuterium has been found to impact cell division.. When it gets incorporated into proteins in the body it can mess with their functionality. Yet at such low concentrations it seems like it wouldn't be a significant issue. Let's get to the bottom of this. Dr. Laszlo Boros is a retired Professor of Pediatrics at the UCLA School of Medicine, the Co-Director of the Stable Isotope Research Laboratory at the Lundquist Institute for Biomedical Innovations and Investigator at the Clinical and Translational Research Institute at the Harbor-UCLA Medical Center. He is the inventor of the Human Deutenome Project in order to map the distribution of deuterium in the human body with structural and functional interpretations as it relates to disease and health. Born and educated in Hungary, his medical background includes a focus on pancreatic cancer and stable isotope technologies to study diabetes and cancer cell growth in vitro. He researches the influence of metabolic processes and disorders on aggressive cancers and vitamin transport. He is an internationally recognized expert of metabolic water biochemistry as well as deuterium mediated kinetic isotopic effects in health and disease. His most recent studies target 'deupletion' and 'deuposition' related mechanisms as the result of intra-cellular hydrophobic lipid membrane nanoconfinements via the Quantum Destabilization of Protons in metabolic water. https://www.laszlogboros.com/_files/ugd/aeaa87_81191bea9f9643a7b40ed99f0052394d.pdf Support The Rational View at https://patron.podbean.com/TheRationalView This was an interesting discussion. What did you think? Let me know @TheRationalView on Facebook.

In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews John Ayers, PhD, MA, vice chief of innovation in the Division of Infectious Diseases & Global Public Health, deputy director of informatics in the Altman Clinical and Translational Research Institute, and affiliate scientist in the Qualcomm Institute, all at UC San Diego, to discuss how genAI programs like ChatGPT can increase communication pathways and improve patient outcomes. Related Content: How AI Assistants Could Help Answer Patients' Messages—and Potentially Improve Their Outcomes

What happens if an astronaut dies in space? Emmanuel Urquieta, assistant professor in the Center for Space Medicine at Baylor University, considers the options. Dr. Emmanuel Urquieta currently serves as Chief Medical Officer at the NASA funded Translational Research Institute for Space Health, where he manages research projects in areas ranging from radiation protection to […]

Space & bio – we finally have the 2nd episode in our subseries on this topic. Dorit Donoviel is the Director of the Translational Research Institute for Space Health. TRISH is an institute that is cooperating with NASA and conducting a fascinating range of research regarding human health in space. Our discussion touches on many topics, ranging from challenges to human physiology in microgravity all the way to the question of whether we can use gene editing to adapt ourselves to the space environment. Enjoy! SPACE ECONOMY BOOK: Raphael's fully revised introductory book on the Space economy, "To Infinity" - https://a.co/d/6jIQ2LO Upcoming newsletter - sign up: https://spacebusiness.substack.com/ Follow us: Twitter - https://www.twitter.com/podcast_space LinkedIn - https://www.linkedin.com/in/raphaelroettgen/ Instagram -  www.instagram.com/raphael_space/ Learn more about space & the space economy: Check out the edX/EPFL Space Economy MOOC: https://www.edx.org/course/new-space-economy The Space Business Podcast is sponsored by NanoAvionics. Support us at https://www.patreon.com/spacebusinesspodcast Timestamps 0:00 Intro 2:35 TRISH 3:50 Staying healthy in space 7:36 Health concerns in microgravity 12:07 Eye and brain issues 13:40 Artificial gravity 15:40 Licensing 18:46 Moon & Mars 22:50 Medical equipment and treatment in space 27:00 Surgery 29:22 Positive effects in space 33:03 Longevity in space 34:50 Gene editing 39:28 Reproduction in space 43:33 Research projects if more funding was available 45:23 Food production 47:31 Astronaut health monitoring 50:00 Beyond R&D 53:55 Organ-on-chip models 56:33 How one can get involved in TRISH 1:00:17 Sci-fi

In this episode, Dr. Bret Goodpaster, Researcher at AdventHealth Translational Research Institute in Orlando, Florida joins the podcast to discuss research being conducted that aims to examine how well we age and how to help mature adults get the most out of life.

There are increasing cases of young adults suffering from heart attacks. Obesity is the prime cause of it. Sedentary lifestyle, alcohol and drugs addiction, constant stress are some of the prime reasons cited for increasing obesity. In today's episode, we discuss the relationship between addiction and obesity. What causes addiction? Where does this stem from and how it leads to obesity and other health related problems? Tune in now, to learn how you can train your brain to avoid addiction and obesity. [00:37] - About Selena Bartlett Professor Bartlett is a Group Leader of Addiction and Obesity and a Translational Research Institute, The Institute of Health and Biomedical Innovation. She is a professor in clinical studies at the Queensland University of Technology. Professor Bartlett is a widely published author and commentator on addiction, obesity and smashing the mindset.  --- Support this podcast: https://podcasters.spotify.com/pod/show/tbcy/support

Dr Glenn McConell chats with Dr Paul Cohen from Translational Research Institute for Metabolism and Diabetes, AdventHealth Orlando, Florida, USA. He has a very strong track record of research examining muscle mitochondria in health and disease and in particular the effects of exercise in attenuating the reductions in mitochondrial function with age. A very interesting chat. Twitter: @CoenPM 0:00. Introduction/Paul's exercise research training 3:10. Exercise, aging and inflammation markers etc 5:55. Bret Goodpaster/Advent Health 8:53. Muscle mitochondria functions 10:15. Mitochondria: energetics, function, biogenesis 13:11. Effects of aging on mitochondria 16:15. Mitochondria energetics, VO2 max and muscle power with age 22:30. Isolated mito vs fibers vs in vivo measures of mito 24:52. Changes with aging per se vs inactivity with aging 28:40. Can mimic exercise using isolated mito measures? 32:03. Time course of mito changes with age vs physical activity 34:00. Is walking enough to maintain mitochondrial volume etc? 35:40. The body and the response to exercise is very integrative 37:25. Lipids in muscle and mitochondrial function 39:00. Subcellular vs intramyofibullar mitochondria 42:55. Mitochondrial energetics and mobility as age etc 44:45. Medications vs exercise 46:08. Aging, mitochondria respiration and leg power 47:40. Aging, mitochondrial energetics and fatigue 49:10. Sex differences in mitochondrial energetics 50:25. Aging vs physical inactivity with aging 52:00. Aging, mitochondria, gait speed and mortality 54:08. If do one thing best to do aerobic or weight training? 56:12. The best exercise is the exercise that people will do 56:10. Social interaction 57:20. Exercise for health span vs life span/“Stop aging” 1:00:12. Healthy aging when have a well managed disease? 1:01:52. Markers of healthy aging 1:03:05. Inherited and acquired mito DNA sequence variations 1:06:10. Nitrate supplementation, mitochondria and aging 1:09:05. Bed rest, diabetes, muscle mass and mitochondrial 1:13:15. Takeaway messages 1:14:43. Links between mitochondrial function and insulin sensitivity? 1:18:43. Outro (9 seconds) Inside Exercise brings to you the who's who of research in exercise metabolism, exercise physiology and exercise's effects on health. With scientific rigor, these researchers discuss popular exercise topics while providing practical strategies for all. The interviewer, Emeritus Professor Glenn McConell, has an international research profile following 30 years of Exercise Metabolism research experience while at The University of Melbourne, Ball State University, Monash University, the University of Copenhagen and Victoria University. He has published over 120 peer reviewed journal articles and recently edited an Exercise Metabolism eBook written by world experts on 17 different topics (https://link.springer.com/book/10.1007/978-3-030-94305-9). Connect with Inside Exercise and Glenn McConell at: Twitter: @Inside_exercise and @GlennMcConell1 Instagram: insideexercise Facebook: Glenn McConell LinkedIn: Glenn McConell https://www.linkedin.com/in/glenn-mcconell-83475460 ResearchGate: Glenn McConell Email: glenn.mcconell@gmail.com Subscribe to Inside exercise: Spotify: shorturl.at/tyGHL Apple Podcasts: shorturl.at/oFQRU YouTube: https://www.youtube.com/@insideexercise Anchor: https://anchor.fm/insideexercise Google Podcasts: shorturl.at/bfhHI Anchor: https://anchor.fm/insideexercise Podcast Addict: https://podcastaddict.com/podcast/4025218 Not medical advice

Dr. Emmanuel Urquieta is the chief medical officer for the Translational Research Institute for Space Health, or TRISH, a Houston organization based out of Baylor College of Medicine that's leading space health research. Emmanuel joins the show to talk about TRISH and its ongoing research including its most recent mission with Axiom Space that was completed last week.

This episode features Dr. Anna Casu, Associate Investigator at Translational Research Institute - AdventHealth. Here, she discusses the work AdventHealth is doing with TZIELD, the first FDA approved drug that can delay the progression of Type 1 diabetes by up to three years in adults and up to eight years in children, how the screening and treatment work, what it takes to get a drug FDA approved, and more.

This episode features Dr. Anna Casu, Associate Investigator at Translational Research Institute - AdventHealth. Here, she discusses the work AdventHealth is doing with TZIELD, the first FDA approved drug that can delay the progression of Type 1 diabetes by up to three years in adults and up to eight years in children, how the screening and treatment work, what it takes to get a drug FDA approved, and more.

Dr Laszlo Boros is Professor Emeritus of Pediatrics at the UCLA School of Medicine, where he spent years in biochemical laboratory research, and is recognized as an internationally recognized expert of metabolic water biochemistry as well as deuterium-mediated kinetic isotopic effects on health and disease. While there, he was Co-Director of the Stable Isotope Research Laboratory at the Lundquist Institute for Biomedical Innovations (LUNDQUIST) and Investigator at the Clinical and Translational Research Institute at the Harbor-UCLA Medical Center with a primary focus on studying cancer cell metabolism. Now in his native country of Hungary, he teaches Deuterium based biomechanics and biochemistry (Deutenomics) at the University level. Watch this episode for a masterclass on the workings of your mitochondria in health and disease, how this can be disrupted by excess deuterium, and what you can do about it. Enjoy! CONTACT DR BOROS www.laszlogboros.com   And special thank you to the sponsor of this episode, The Carnivore Bar! Use discount Code "Anthony" for 10% off all orders! https://the-carnivore-bar.myshopify.com/?sca_ref=1743809.v3IrTuyDIi   Contact and Follow Dr Chaffee: ✅PATREON for early releases, bonus content, and weekly Zoom meetings https://www.patreon.com/AnthonyChaffeeMD ✅Sign up for our 30-day carnivore challenge and group here! https://www.howtocarnivore.com/ ✅INSTAGRAM: @anthonychaffeemd www.instagram.com/anthonychaffeemd/ ✅TWITTER: @Anthony_Chaffee ✅TIKTOK: @AnthonyChaffeeMD ✅Apple Podcast: The Plant Free MD https://podcasts.apple.com/au/podcast/the-plant-free-md-podcast/id1614546790 ✅Spotify: The Plant Free MD https://open.spotify.com/show/0WQtoPLuPMWWm3ZT3DYXzp?si=PPc2rXZzQXuzjIRK__SEZQ ✅To Sign up for a personal consultation with me, you can use my Calendly link below to schedule an appointment: ✅60 minute consultation https://calendly.com/anthonychaffeemd/60-minute-consultation ✅For collaborations, please email me at the below address. Please understand that I cannot give advice over email, but only in a consultation setting: AnthonyChaffee@gmail.com For more of my interviews and discussions, as well as other resources, go to my Linktree at: ✅ https://linktr.ee/DrChaffeeMD OR my website at: ✅ www.TheCarnivoreLife.com   Affiliate Links: ✅X3 bar system with discount code "DRCHAFFEE" https://www.kqzyfj.com/click-100676052-13511487 ✅THE CARNIVORE BAR: Discount Code "Anthony" for 10% off all orders! https://the-carnivore-bar.myshopify.com/?sca_ref=1743809.v3IrTuyDIi ✅CARNIVORE CRISPS: Discount Code "DRCHAFFEEMD" for 10% off all orders! www.carnivorecrisps.com ✅Shop Amazon https://www.amazon.com/shop/anthonychaffeemd?ref=ac_inf_hm_vp   And please like and subscribe to my podcast here and Apple/Google podcasts, as well as my YouTube Channel to get updates on all new content, and please consider giving a 5-star rating as it really helps! Music track: Acoustic Breeze from Bensound.com #nutrition #keto #bodybuilding #carnivore #fyp #motivation #carnivore #carnivorediet #weightloss #thecarnivorelife #weightsandsteaks #teamcarnivore #meatheals #yestomeat #nutrition #diet #autoimmune #rugby #rugbyunion #rugbyplayer #weightlossjourney #weightlifting #steak #bodybuilding #strength #strengthtraining #weighttraining #zerocarb #keto #ketovore #ribeye #liondiet #ketodiet #carnivoreketo #ketotransformation #carnivore75hard #vegan #sowell #thomassowell #dairy #milk #cheese #nsng #lchf #lcif

Dr. Jennifer A. Fogarty, Ph.D. ( https://www.bcm.edu/people-search/jennifer-fogarty-100936 ) is the Chief Scientific Officer for the Translational Research Institute for Space Health ( TRISH - https://www.bcm.edu/academic-centers/space-medicine/translational-research-institute ) at Baylor College of Medicine, and the Director of the Applied Health and Performance at Sophic Synergistics LLC. As Chief Scientist of TRISH, Dr. Fogarty leads an innovative and high-risk research and technology development portfolio to address the most challenging human health and performance risks of space exploration. At Sophic Synergistics, which is a women-owned and women-led Human Centered Design firm specializing in integrating human factors engineering and human health and performance into a business model, Dr. Fogarty's Division focuses on developing and expanding the application of medical technologies for use in remote medicine, telemedicine, and home healthcare. In both roles, Dr. Fogarty's goal is to increase access to high quality healthcare and empower patients and medical providers by incorporating precision medicine and cutting-edge science and technology with actionable data both in space and on Earth. Dr. Fogarty has over twenty years of experience in medical physiology and extreme environments and was the NASA Human Research Program Chief Scientist. Her approach prioritizes communication and collaboration with industry academia, government and commercial spaceflight programs, and international partners. She values and seeks collaborations with external institutions and government agencies to assess fundamental and mechanistic discoveries as well as innovative prevention and treatment strategies for application to preserve health and performance. Dr. Fogarty has a Ph.D. in Medical Physiology from Texas A&M University School of Medicine and a B.S. in Biology from Stockton University . She is currently an Assistant Professor in the Department of Medicine at Baylor College of Medicine, an editor of the Fundamentals of Aerospace Medicine 4th and 5th edition, and associate editor for the journal npj Microgravity.

Welcome to Protecting Your Nest with Dr. Tony Hampton. Ambrish Sharma is an entrepreneur, healthcare innovator, and informatist focused on health literacy, health equity, and patient engagement. He is the senior informatics research manager with Oregon Clinical and Translational Research Institute. He is also the co-founder and COO of the website, MedAugeo. His background is in healthcare, medicine, and medical informatics. In this discussion, Dr. Tony and Ambrish talk about: (04:03) A little bit about Ambrish's personal life and family support (07:27) How Ambrish got started in his professional career and how he uses his many specialties to help people (11:06) Ambrish's medical history and experience working to improve his own health (16:16) Areas that need improvement in the healthcare system in the United States (21:12) The role that social determinants of health play in a person's overall wellbeing and ability to be successful with their health related goals (27:48) Making health information widely available to people of different cultural, socioeconomic, and educational backgrounds (34:22) Engaging with community health workers as a part of a patient engagement and health literacy strategy (37:58) How to reach minority communities and different cultural groups with health information (41:21) Video and digital delivery for health information (46:11) Ambrish's goals when it comes to helping others and reaching people with health information that they may desperately need Thank you for listening to Protecting Your Nest. For additional resources and information, please see the links below.    Links:   Ambrish Sharma: MedAugeo Email 1: team@medaugeo.com Email 2: ambrish.sharma@medaugeo.com   Dr. Tony Hampton: Linktree Instagram Account LinkedIn Account Ritmos Negros Podcast Q Med Symposium for Metabolic Health Lectures

In this week's episode let's talk about brain training!  Professor Selena Bartlett is a Group Leader in Neuroscience and Neuroplasticity at the Translational Research Institute and a Research Capacity Building Professor at QUT. Join us for a fantastic conversation about brain training, flow states and the importance of working in teams for creativity.  Links/References Selena Bartlett: https://www.linkedin.com/in/drselenabartlett/ Selena Bartlett website: https://www.profselenabartlett.com/ Thriving Minds Podcast: https://podcasts.apple.com/us/podcast/thriving-minds/id1471835230 The Common Creative Podcast (Paul and Chris): https://creativecommons.org.au The Common Creative (Mailing List Subscriptions): http://eepurl.com/hgp0_jSee omnystudio.com/listener for privacy information.

If you're looking to dive deep into the science of the carnivore diet and learn about deutenomics from the leading pioneer of the field, then this episode is for you. Dr. Boros is an internationally recognized expert on metabolic water biochemistry as well as deuterium-mediated kinetic isotopic effects on health and disease. Deutenomics is a substantial field in functional biochemistry and the metabolic phenotype. Dr. Boros is the co-inventor of Deutenomics to study deuterium as an oncoisotope and its depletion by mitochondrial matrix water exchange reactions to prevent oncoisotopic cell transformation or maintain fertility. Dr. Boros is a retired (2021) Professor of Pediatrics at the University of California Los Angeles (UCLA) School of Medicine, the Co-Director of the Stable Isotope Research Laboratory at the Lundquist Institute for Biomedical Innovations (LUNDQUIST), and an Investigator at the Clinical and Translational Research Institute at the Harbor-UCLA Medical Center with a primary focus on studying cancer cell metabolism. In this episode you will discover: The science and metabolism of deuterium How to feed your body with “high-quality fuel” Deuterium and pregnancy, reducing chromosomal damage How much water is too much The power of fasting Connect with Dr. Boros: Website Facebook Connect more with Dr. Kiltz Website Keto + Carnivore Support - Group Kiltz Mighty Tribe Kiltz Cups Doctor Kiltz Nutritional Solutions Instagram Tiktok Facebook Twitter Amazon Books by Dr. Kiltz

Elon Musk is building the rockets that will send the next generation of astronauts to Mars, but they won't stand a chance of surviving the journey if not for the research being done by scientists like Dorit Donoviel, Ph.D. Dorit joined us to talk about inventing new ways to keep humans alive and healthy on multi-year missions into deep space. Dorit Donoviel is the Executive Director of NASA's Translational Research Institute for Space Health and Professor of Space Medicine at Baylor College of Medicine. Follow her fascinating work on Twitter at @DoritPhD. This interview was recorded as part of Dan Crenshaw's Healthcare Innovation Summit at Rice University in Houston, TX.

This episode features Dr. Bret Goodpaster, Professor and Senior Scientist at Translational Research Institute for Metabolism and Diabetes. In this conversation, he discusses the importance of preventative health, how genetics shape health, understanding how exercise is good for people on a molecular level, and more.

In this episode: We meet Dr. Dorit Donoviel, director of the Translational Research Institute for Space Health (TRISH). She is also director of the Biomedical Innovation Laboratory and associate professor of Space Medicine at Baylor College of Medicine. Donoviel's work revolves around performing research and developing strategies aimed at reducing health and safety risks to astronauts in long-duration space missions. She has received numerous awards for her work, including NASA's Group Achievement Award for work as a member of the Executive Steering Committee for “The Impact of Sex and Gender on Adaptation to Space,” a collection of six scientific articles published in The Journal of Women's Health. In our conversation Donoviel discusses how her career in the space ecosystem began, what inspired her to do the research she does, changes that occur in the human body in space, how space health includes both physical and behavioral health, the TRISH-sponsored research conducted by the civilian crew on the SpaceX Inspiration4 mission, and her thoughts on the importance of mentorship. Explaining the importance of racial and gender diversity in tracking the health of humans in space, Donoviel says, “You go back to the Sixties; we've been in space for 60 years… Roughly 530-something-odd people have been to space. That's like 10 a year. And as a biologist — as a person who studies particularly humans — you need more than that! You need a lot more people. And you need diversity in your sample.” To learn more about TRISH, visit https://www.bcm.edu/academic-centers/space-medicine/translational-research-institute Introductory and closing music: Paint the Sky by Hans Atom © Copyright 2015, licensed under a Creative Commons Attribution (3.0) license. http://dig.ccmixter.org/files/hansatom/50718 Ft: Miss Judged

Let's talk about brain training!Professor Selena Bartlett is a Group Leader in Neuroscience and Neuroplasticity at the Translational Research Institute and a Research Capacity Building Professor at QUT. Join us for a fantastic conversation about brain training, flow states and the importance of working in teams for creativity.Links/ReferencesSelena Bartlett: https://www.linkedin.com/in/drselenabartlett/Selena Bartlett website: https://www.profselenabartlett.com/Thriving Minds Podcast: https://podcasts.apple.com/us/podcast/thriving-minds/id1471835230The Common Creative Podcast (Paul and Chris): https://creativecommons.org.auThe Common Creative (Mailing List Subscriptions): http://eepurl.com/hgp0_jSee omnystudio.com/listener for privacy information.Support the show (https://www.patreon.com/selenab)

Let's talk about brain training! Professor Selena Bartlett is a Group Leader in Neuroscience and Neuroplasticity at the Translational Research Institute and a Research Capacity Building Professor at QUT. Join us for a fantastic conversation about brain training, flow states and the importance of working in teams for creativity. Links/References Selena Bartlett: https://www.linkedin.com/in/drselenabartlett/ Selena Bartlett website: https://www.profselenabartlett.com/ Thriving Minds Podcast: https://podcasts.apple.com/us/podcast/thriving-minds/id1471835230 The Common Creative Podcast (Paul and Chris): https://creativecommons.org.au The Common Creative (Mailing List Subscriptions): http://eepurl.com/hgp0_jSee omnystudio.com/listener for privacy information.

Astrid is a post doctoral researcher at the Translational Research Institute and founder of Project Huitcaca, a non-for-profit aiming to support Latin American women in Science. She talks to us about her career journey, the mission of Project Huitaca, and what we can do to help.

On Wednesday's Houston Matters: Electricity is back for all but about 80,000 CenterPoint Energy customers in the Houston metro area, but, as we largely escaped the worst of Nicholas, some communities south and east of us saw a little more damage. We check in with Brazoria County Judge Matt Sebesta about storm surge damage and flooding in Surfside Beach. Also this hour: We break down the latest news in our weekly political roundup. Then, today the Inspiration4 ​crew is scheduled to launch into space, becoming the first-ever all-civilian orbital flight around the earth. Launching with them will be several experiments designed to study their health -- experiments developed by a Houston-based research effort called TRISH, the Translational Research Institute for Space Health. We talk with one of their scientists about what the project will be studying and how it might benefit life back on the ground.  And a documentary that's screening this week tells the stories of students who survived the 2018 school shooting at Santa Fe High School. We talk with Charlie Minn, director of The Kids of Santa Fe: The Largest Unknown Mass Shooting.

Did you know that 75% of Australians are predicted to be overweight or obese by 2025? Neuroimaging studies have shown that high-sugar containing foods and beverages activate reward areas within the brain – that ‘reward’ appears to be more robust than those of cocaine. Brain function is significantly impacted from sugar and food over consumption. This week’s podcast guest Professor Selena Bartlett believes the solution to solving our addiction troubles lies in our head – more specifically, how we train our brains. Professor Selena Bartlett is a Group Leader in Neuroscience and Obesity at the Translational Research Institute. She was awarded the Lawrie Austin Award for her contributions to Neuroscience by the Australian Neuroscience Society in 2019, recipient of the Biotech Research Award and was an Ambassador for the Women in Technology organisation. The overarching objectives of her research program is to apply a neuroscientific translational research and development approach to improve sugar addiction. Listen in as Selena delves into how sugar activates our addiction centres and changes the physical structure of the brain. Selena also discusses how she is using a neuroscience approach to combat addiction that focuses on retraining the brain.

Two distinguished scientists join me for a discussion of the optimal public-health response to the challenges posed by COVID-19. Martin Kulldorff is a Professor of Medicine at Harvard Medical School. His research centers on developing new epidemiological and statistical methods for the early detection and monitoring of infectious disease outbreaks and for post-market drug and vaccine safety surveillance. Eric Topol is a Professor of Molecular Medicine at Scripps Research, founder and director of its Translational Research Institute, a practicing physician, and one of the top 10 cited medical researchers.

Wonderful discussion with my old friend, research and spiritual mentor Dr. Paul Mills. Paul J. Mills was Professor of Family Medicine and Public Health and Director of the Center of Excellence for Research and Training in Integrative Health. He was also Chief of the UC San Diego Behavioral Medicine Division, Director of the UC San Diego Clinical Research Biomarker Laboratory, and Co-director of the UC San Diego Clinical and Translational Research Institute’s Translational Research Technology (TRT) Program. He is currently serving as Director of Research for the Chopra Foundation. He has expertise in Integrative Medicine, Traditional Medical systems, and psychoneuroimmune processes in wellness and disease, publishing numerous manuscripts and book chapters on these topics. Dr. Paul Mills has been an inspirational figure in many lives, we look back on his career and forward to his continued work bridging the spiritual and the scientific. Enjoy.

On this episode, we are joined by Dr. Emmanuel Urquieta. Dr. Urquieta is a physician and the deputy chief scientist at the Translational Research Institute for Space Health. He is also an assistant professor of emergency and space medicine at Baylor College of Medicine. Dr. Urquieta was also a mission specialist for NASA's HERA XI mission in 2016.  hanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable Power Point slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

Dear Friends & Colleagues,Welcome back to the Fall 2020 season of ‘Creating a New Healthcare’.  We are now entering the 4th year of our podcast, with over 250,000 downloads this year to date!  It’s clear that the issue of reframing healthcare has never been more important than it is at this moment.  So, if you find value in listening to the podcast, I would urge you to share it with friends and colleagues.  There is so much going on in the world right now. It’s a time of great uncertainty, volatility, distress - and opportunity.   One of the unintended consequences of the sheltering-at-home and social-distancing - necessary to combat COVID-19 - is the devastating isolation, loneliness and despair it has wreaked across the US population.  Research, prior to the pandemic, informs us that somewhere between 40 - 50% of the population experiences social isolation or loneliness.  I strongly suspect that the pandemic has raised those numbers significantly.  We also know that it’s not just the elderly.  The second most affected segment of the population are college age adults.  We desperately need a national solution to address social isolation and loneliness. So, what can NASA teach us about social isolation & loneliness?  And, why is Humana, a major healthcare insurance company, collaborating with NASA to address social isolation?To answer those questions, we’ll be joined today by two distinguished experts in this area - Dr. Will Shrank,  the Chief Medical Officer at Humana; and Dr. Gary Strangman - a psychologist and researcher from the Massachusetts General Hospital (MGH).  Dr. Strangman is the Director of a “Neural Systems Group” at MGH and has also been working closely with NASA over the past 2 decades - currently as the Innovation Specialist for NASA’s Translational Research Institute for Space Health (TRISH).In this interview, we’ll dive into the following:The physiologic and psychologic impact of social isolation on astronauts and the types of solutions NASA is exploring to deal with this.Some of the similarities between space travel & sheltering-at-home in the era of COVID-19.Startling statistics on the impact of social isolation on Humana’s senior members, and the types of initiatives they’ve been deploying to combat it.Next steps for the collaboration between Humana and TRISH.During the interview it becomes abundantly apparent that Gary Strangman and Will Shrank are superstars in their respective fields.  The fact that Humana is collaborating with NASA’s Translational Institute for Space Health speaks volumes about the intense focus, commitment and highly innovative approach Humana is taking to better understand and combat the epidemic of social isolation.  Humana and TRISH are also collaborating, alongside others, in a public health awareness campaign, called ‘Far from Alone’.  This program addresses health-related social needs and promotes understandings of loneliness and social isolation - issues that are exacerbated by the Coronavirus pandemic. I recently read a quote from Atul Gawande that provides a meaningful context to the work that Dr. Shrank and Dr. Strangman, and their respective organizations, are engaged in.  “We’ve been wrong about what our job is in medicine. We think our job is to ensure health and survival.  But really it is larger than that. It is to enable well-being. And well-being is about the reasons one wishes to be alive." Until Next Time,Be Safe & Be Well.Zeev Neuwirth MD 

How can medicine continue to research, innovate, and provide regular patient care during the COVID-19 pandemic? Gary Firestein, MD, director of the Clinical and Translational Research Institute, dean and associate vice chancellor for clinical and translational research, and a professor of medicine at UC San Diego School of Medicine, shares how clinical trials are currently being conducted and how telehealth is being increasingly embraced. He also shares his perspective on finding balance in life as a medical professional. Series: "Compassion Forum" [Health and Medicine] [Show ID: 36044]

How can medicine continue to research, innovate, and provide regular patient care during the COVID-19 pandemic? Gary Firestein, MD, director of the Clinical and Translational Research Institute, dean and associate vice chancellor for clinical and translational research, and a professor of medicine at UC San Diego School of Medicine, shares how clinical trials are currently being conducted and how telehealth is being increasingly embraced. He also shares his perspective on finding balance in life as a medical professional. Series: "Compassion Forum" [Health and Medicine] [Show ID: 36044]

How can medicine continue to research, innovate, and provide regular patient care during the COVID-19 pandemic? Gary Firestein, MD, director of the Clinical and Translational Research Institute, dean and associate vice chancellor for clinical and translational research, and a professor of medicine at UC San Diego School of Medicine, shares how clinical trials are currently being conducted and how telehealth is being increasingly embraced. He also shares his perspective on finding balance in life as a medical professional. Series: "Compassion Forum" [Health and Medicine] [Show ID: 36044]

How can medicine continue to research, innovate, and provide regular patient care during the COVID-19 pandemic? Gary Firestein, MD, director of the Clinical and Translational Research Institute, dean and associate vice chancellor for clinical and translational research, and a professor of medicine at UC San Diego School of Medicine, shares how clinical trials are currently being conducted and how telehealth is being increasingly embraced. He also shares his perspective on finding balance in life as a medical professional. Series: "Compassion Forum" [Health and Medicine] [Show ID: 36044]

How can medicine continue to research, innovate, and provide regular patient care during the COVID-19 pandemic? Gary Firestein, MD, director of the Clinical and Translational Research Institute, dean and associate vice chancellor for clinical and translational research, and a professor of medicine at UC San Diego School of Medicine, shares how clinical trials are currently being conducted and how telehealth is being increasingly embraced. He also shares his perspective on finding balance in life as a medical professional. Series: "Compassion Forum" [Health and Medicine] [Show ID: 36044]

How can medicine continue to research, innovate, and provide regular patient care during the COVID-19 pandemic? Gary Firestein, MD, director of the Clinical and Translational Research Institute, dean and associate vice chancellor for clinical and translational research, and a professor of medicine at UC San Diego School of Medicine, shares how clinical trials are currently being conducted and how telehealth is being increasingly embraced. He also shares his perspective on finding balance in life as a medical professional. Series: "Compassion Forum" [Health and Medicine] [Show ID: 36044]

How can medicine continue to research, innovate, and provide regular patient care during the COVID-19 pandemic? Gary Firestein, MD, director of the Clinical and Translational Research Institute, dean and associate vice chancellor for clinical and translational research, and a professor of medicine at UC San Diego School of Medicine, shares how clinical trials are currently being conducted and how telehealth is being increasingly embraced. He also shares his perspective on finding balance in life as a medical professional. Series: "Compassion Forum" [Health and Medicine] [Show ID: 36044]

How can medicine continue to research, innovate, and provide regular patient care during the COVID-19 pandemic? Gary Firestein, MD, director of the Clinical and Translational Research Institute, dean and associate vice chancellor for clinical and translational research, and a professor of medicine at UC San Diego School of Medicine, shares how clinical trials are currently being conducted and how telehealth is being increasingly embraced. He also shares his perspective on finding balance in life as a medical professional. Series: "Compassion Forum" [Health and Medicine] [Show ID: 36044]

Ned and Meg talk about the Translational Research Institute for Space Health! The first week of June we will participate in a series of webinars on behavioral health and performance in space! Wash your hands! Wear a mask!

Dr. Dorit Donoviel and Dr. Kristin Fabre, Director of TRISH and Senior Innovation Scientist, are helping NASA solve challenges and prepare for deep space travel through the Translational Research Institute for Space Health (TRISH) by connecting with the most innovative technology, companies and researchers all over the world. HWHAP Episode 143.

Dr. Dorit Donoviel and Dr. Kristin Fabre, Director of TRISH and Senior Innovation Scientist, are helping NASA solve challenges and prepare for deep space travel through the Translational Research Institute for Space Health (TRISH) by connecting with the most innovative technology, companies and researchers all over the world. HWHAP Episode 143.

Dr. Dorit Donoviel and Dr. Kristin Fabre, Director of TRISH and Senior Innovation Scientist, are helping NASA solve challenges and prepare for deep space travel through the Translational Research Institute for Space Health (TRISH) by connecting with the most innovative technology, companies and researchers all over the world. HWHAP Episode 143.

On this, episode 15 of Season 3, our last episode from DOCSF2020, our case study will feature a company that has real world experience on how the use of data and analytics can solve real problems for their client health institutions. Jean Drouin, the charismatic CEO and Founder of Clarify Health developed many insights while working side by side with Tony Blair rebuilding the NHS many years ago as a consultant for Mckinsey and company. He explains the power of data to the audience at DOCSF 2020 and takes questions from the moderator, Dr. Aenor Sawyer Chief Health Innovation officer for the Translational Research Institute for Space Health at UCSF. Please join them on stage as they close out the DOCSF 2020 conference.  The Venue: This conversation was recorded at DOCSF in January 2020, the weekend before #JPM Week in San Francisco. DOCSF is all about the intersection of digital health and musculoskeletal care. This year, the sessions featured leaders from Microsoft, Google, Mozilla, Amazon and many other amazing organizations, and Dan Kendall interviewed some of the speakers following their sessions on the stage. This special series of episodes features some of the interviews recorded at this annual event. To hear all the sessions on the DOCSF podcast, be sure to subscribe to the DOCSF Podcast here or visit Health Podcast Network. Get more content: ·      Browse episodes on Digital Health Today  ·      Browse episodes on the DOCSF Podcast ·      Follow Digital Health Today on Twitter, Linkedin, Facebook and Instagram ·      Follow the Health Podcast Network on Linkedin, Twitter, Facebook and Instagram

There is no clear agreement as to what constitutes a rare disease, the actual number of rare diseases, and how individual rare diseases are defined. The lack of clarity on the matter is not just an academic issue. The consequences of this, say researchers, is that it slows the diagnostic process and impedes the development of needed therapies for these conditions. In a recent commentary in the journal Nature Reviews Drug Discovery, Melissa Haendel and her co-authors discuss their efforts to characterize, define, and harmonize the definitions of rare disease through the Monarch Disease Ontology initiative. We spoke to Haendel, associate professor of medical informatics and clinical epidemiology at the Oregon Clinical and Translational Research Institute, about the problem with the different way organizations characterize and define rare diseases, the challenges of aligning these definitions, and why harmonization is critical for making progress in diagnosing and treating these conditions.

MTPConnect is officially open for business in Queensland, after the launch of our new offices at the Translational Research Institute in Brisbane! Minister for Industry, Science and Technology Hon. Karen Andrews MP was on hand to open our offices and announce the IMNIS Regional Queensland Initiative that will see six PhD students from James Cook University and six students from CQ University have access to industry mentors in their university program. IMNIS Executive Director Dr Marguerite Evans-Galea AM, IMNIS mentor Kym Baker from Patheon and IMNIS mentee Nick Lee were also there to share the impact of IMNIS on their professional journeys.Credits: Host Stuart Dignam

Dr Fiona Simpson is a Senior Research Fellow at The University of Queensland Diamantina Institute, Brisbane, Australia.  She grew up in the Highlands of Scotland, where she was the top of her class, at the same time, she was working 3 jobs to keep the family home afloat. Her father died at the age of 10 and left her mother clinically depressed. At the time, there was no help for a woman left to raise the kids. Fiona found herself in difficult times and angry and let this out in self-destructive ways, from addiction to violence. One night she was walking to the cliffs and not wanting to live anymore. One man, Ian McGregor, took her under his arms and showed her love and saved her life. We discuss her life experience, the beauty and love of people that care enough. This lead to a PhD in Cambridge and a prestigious fellowship to Scripps in California, United States. She has made significant scientific discoveries and now is changing the face of how we use current immunotherapies for head&neck cancer, breast and melanoma cancers. It takes a lot of guts to have the courage to face your biggest fears of being alone and exhausted and desperate. When we break through our fears, on the other side, lives glory.  Dr Fiona Simpson is raising money to bring high school students to have work experience at the Translational Research Institute. Learn more about Dr Simpson research findings: https://di.uq.edu.au/profile/1006/fiona-simpson-simpson-fraserhttp://qhncc.org.au/fiona-simpson/https://www.projectpink.org.au/news/1Support the showLearn more at www.profselenabartlett.com

Interview with Tia Levine and Angela Griffiths discussing ACTRI. ACTRI is the UC San Diego Altman Clinical and Translational Research Institute developed to advance scientific discovery to improve health – bringing discoveries from the lab to the bedside. This podcast series is hosted by Patricia Kathleen and Wilde Agency Media. The series interviews female and female-identified entrepreneurs, founders, business owners, and gurus across all industries to investigate women (and women identified individuals) in business today. Both the platform and discussion are designed to further the global conversation in regards to the changing climate of female (and female-identified individuals) in entrepreneurial and founding roles.

The Oregon Clinical and Translational Research Institute, OCTRI, community research hub is working to improve the health and wellness of all Oregonians. Engaging researchers, community members and organizations together - to support each other in community-based research. Guests include: Jackie Shannon - Professor Steven Blakesley – OCTRI, Senior Research Assistant Marlene Putman - Administrator, Tillamook County Health & Human Services Department

Hey Check out Selena Bartlett's new podcast: SHINING MIND Professor Selena Bartlett is a Group Leader in Neuroscience and Obesity at the Translational Research Institute at the Institute of Health and Biomedical Innovation and a Research Capacity Building Professor in the School of Clinical Sciences, Faculty of Health, QUT. Dr Bartlett is the CEO and Founder of MiGFiT Inc, a QUT Bluebox start-up spun out her research lab that is focussed on retraining mindset for emotional eating fitness. The biggest problem in diets that fail. She won the Outstanding Achievement Award and the Biotech Research Award and was an Ambassador for the Women in Technology organization. Professor Bartlett recently launched three books to raise awareness and education of the role of the sugar addiction in stress and the development of obesity. She presented a TEDx talk about the brain fitness and neuroplasticity revolution underway and the brain vitality index mobile app. She gives public lectures to organizations, governments, Universities and schools to raise awareness of the importance of brain fitness to health and vitality.

Lisa Suennen, Leader, Manatt Digital & Technology Lisa Suennen is the leader of Manatt Digital and Technology and the firm's venture capital / emerging companies practice. With more than 30 years' experience as an entrepreneur, venture capitalist, board member and strategic advisor, she has focused broadly on new technologies and how they are transforming businesses. She has spent much of her career helping companies adopt and leverage digital technologies, develop strategies for growth through innovation and investment, and build strong collaborations between established players and entrepreneurs. Lisa heads the firm's digital and technology businesses as well as the firm's venture capital fund. She also works closely with Manatt Health, engaging with payers, health systems and companies to provide strategic advice on innovation, digital strategy and growth. Lisa previously served as managing partner of Venture Valkyrie LLC, an advisory firm focused on helping healthcare organizations adopt venture capital and innovation programs and develop new business creation models and digital health strategies. Lisa spent the past 20 years as a venture capitalist, first as a partner with Psilos Group, then leading the healthcare fund at GE Ventures. Prior to that, she was part of the leadership team that built Merit Behavioral Care, an $800 million behavioral healthcare company, guiding it through its successful IPO and exit. Her earlier career focused on product management and marketing in the technology sector. Lisa currently serves on several private company boards and chairs the advisory board of the NASA-funded Translational Research Institute for Space Health. She is also on the faculty at the UC Berkeley Haas School of Business, and is cofounder of CSweetener, which matches women in and nearing the healthcare C-suite with mentors. Additionally, Lisa writes the Venture Valkyrie blog and hosts the Tech Tonics podcast.  

The Translational Research Institute and Vaxxas are supported by MTPConnect through the Growth Centre Initiative to increase Australia's skills and capabilities in manufacturing. This week, we're in Brisbane where our COO Stuart Dignam chats to TRI's Michelle Richards and Vaxxas's Charles Ross to discuss the impact of their projects.

The 2018 Alan Cooper Epiderm Lecture was recently hosted by The University of Queensland Dermatology Research Centre at the Translational Research Institute in Brisbane on Friday 27 July. This year's event featured a keynote presentation by Professor Alan Cooper, ARC Laureate Fellow, Director, Australian Centre for Ancient DNA, Sir Hubert Wilkins Chair of Climate Change, University of Adelaide, on “Evolutionary changes in the human microbiome and immune system”.

Four years ago, BUILD EXITO, an undergraduate research training program, was launched to serve underrepresented communities in biomedical research. The program is organized through the Oregon Clinical and Translational Research Institute, with more than 300 students currently enrolled. OHSU serves as the research-intensive partner, providing crucial support, guidance, and expertise as PSU develops and implements EXITO. Guests include: Keeley McConnell Research Assistant 2

Interview with Lee Hullender Rubin, DAOM, LAc, FABORM Lee is clearly a decorated mover and shaker (see CV below). She is playing such a huge role in furthering the understanding of how Chinese medicine as a whole (which includes but is not limited to acupuncture) can help improve IVF success rates.  Her research is pioneering and is the first to attempt to capture the true holistic essence and power of Chinese medicine, so that healthcare providers and women struggling to get pregnant can more deeply trust and embrace this wonderful resource.  If you haven't done so already, it's time to find yourself a Chinese medicine doctor with experience in reproductive health.  ~ Spence Email drlhrubin@me.com Website http://www.pdxacustudio.com Professional Profile Began practice in Washington state in 2002, and currently has an active license in Oregon since 2011.  Awaiting news of California License. LICENSES and CERTIFICATIONS State of Oregon Acupuncture License #153822 2011 – Present  Oregon Medical Board Supervisor Approval 2011 – Present  Fellow, American Board of Oriental Reproductive Medicine (ABORM) 2008 – Present  Fellow, International Society for the Study of Vulvovaginal Diseases 2017 - Present Diplomate of Oriental Medicine 2005 – Present  National Certification Commission of Acupuncture and Oriental Medicine (NCCAOM)  State of Washington Acupuncture License #1879 2002 – 2016 Diplomate of Acupuncture 2001 – 2005  National Certification Commission of Acupuncture and Oriental Medicine (NCCAOM)  Clean needle certification 1999 Council of Colleges of Acupuncture and Oriental Medicine (CCAOM)  EDUCATION Bachelor of Science 1998 – 2000 Bastyr University, Kenmore WA Natural Health Science in Oriental Medicine Certificate 2001 Shanghai Traditional Chinese Medicine University, Shanghai, PRC 2001 Advanced Herbal Studies in Gynecology, Internal Medicine & Trauma Master of Science 2000 – 2001  Bastyr University, Kenmore, WA Acupuncture and Oriental Medicine Doctor of Acupuncture and Oriental Medicine 2007 – 2009 Oregon College of Oriental Medicine, Portland, OR Women's Health and Geriatrics Capstone: “Acupuncture improves in vitro fertilization pregnancy  rates: a retrospective chart review” Mentors: Richard Hammerschlag, PhD; Tim Chapman, PhD;  Elizabeth Burch, ND Post-Doctoral Research Fellowship 2011 – 2012  Oregon College of Oriental Medicine, Portland OR Certificate 2011 – 2013  Human Investigations Program Oregon Clinical and Translational Research Institute  Oregon Health and Science University, Portland, OR Professional Achievements Lee Hullender Rubin, DAOM, LAc, FABORM, is a clinician, international academic, and published researcher specializing in reproductive medicine, women's health, and female sexual pain.  In practice since early 2002, she spent more than 5 years managing an acupuncture program at a western fertility clinic in the Pacific Northwest. Dr. Hullender Rubin was the first OCOM postdoctoral research fellow funded by a National Institutes of Health educational grant. Her most recent publication is the first cohort study to report an increase in birth outcomes associated with the addition of Traditional Chinese Medicine to In Vitro Fertilization. She recently completed a pilot study investigating the effect of acupuncture and lidocaine to treat chronic vulvar pain. She is on the faculty at the Oregon College of Oriental Medicine, American College of Traditional Chinese Medicine, and New Zealand School of Acupuncture and Traditional Chinese Medicine, and is Visiting Research Faculty at the Oregon Health and Science University. Dr. Hullender Rubin is relocating from Portland, Oregon, and her practices at the Portland Acupuncture Studio and Oregon Reproductive Medicine to San Francisco to pursue her dream job at the Osher Center for Integrative Medicine at UCSF.

J. Craig Venter, founder, chair and CEO of the J. Craig Venter Institute and co-founder of two private genomics companies, recounts his breakthroughs in genome sequencing and shares new research on fighting cancer tumors with personalized vaccines. Venter is presented by the Altman Clinical and Translational Research Institute at UC San Diego. Series: "Wellbeing " [Health and Medicine] [Professional Medical Education] [Show ID: 31734]

J. Craig Venter, founder, chair and CEO of the J. Craig Venter Institute and co-founder of two private genomics companies, recounts his breakthroughs in genome sequencing and shares new research on fighting cancer tumors with personalized vaccines. Venter is presented by the Altman Clinical and Translational Research Institute at UC San Diego. Series: "Wellbeing " [Health and Medicine] [Professional Medical Education] [Show ID: 31734]

J. Craig Venter, founder, chair and CEO of the J. Craig Venter Institute and co-founder of two private genomics companies, recounts his breakthroughs in genome sequencing and shares new research on fighting cancer tumors with personalized vaccines. Venter is presented by the Altman Clinical and Translational Research Institute at UC San Diego. Series: "Wellbeing " [Health and Medicine] [Professional Medical Education] [Show ID: 31734]

J. Craig Venter, founder, chair and CEO of the J. Craig Venter Institute and co-founder of two private genomics companies, recounts his breakthroughs in genome sequencing and shares new research on fighting cancer tumors with personalized vaccines. Venter is presented by the Altman Clinical and Translational Research Institute at UC San Diego. Series: "Wellbeing " [Health and Medicine] [Professional Medical Education] [Show ID: 31734]

"The big challenge for cervical cancer is global," says Prof Ian Frazer (CEO of Translational Research Institute, Brisbane, Australia), developer of the cervical cancer-preventing HPV vaccine. Speaking to ecancertv at the UICC World Cancer Congress 2014, he explains the history of the vaccine's development and his hopes for making it globally accessible.